Single‐cell transcriptome sequencing reveals SPP1 ‐ CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
Journal of Cellular and Molecular Medicine · 2024-07 · 28 (13)
DOI: 10.1111/jcmm.18525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 09.07.2024. Verfasst von Fuzhong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Medical University Affiliated Cancer Hospital, Urumqi, China. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Drug Resistance, Neoplasm, Osteopontin, Single-Cell Analysis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinjiang Medical University Scientific Research Innovation Team Project, Xinjiang Uygur Autonomous Region Natural Science Foundation, Tianchi Young Talent Doctoral Program.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is often considered one of the most aggressive subtypes of breast cancer, characterized by a high recurrence rate and low overall survival (OS). It is notorious for posing challenges related to drug resistance. While there has been progress in TNBC research, the mechanisms underlying chemotherapy resistance in TNBC remain largely elusive. We collect single‐cell RNA sequencing (scRNA‐seq) data from five TNBC patients susceptible to chemotherapy and five resistant cases. Comprehensive analyses involving copy number variation (CNV), pseudotime trajectory, cell–cell interactions, pseudospace analysis, as well as transcription factor and functional enrichment are conducted specifically on macrophages and malignant cells. Furthermore, we performed validation experiments on clinical samples using multiplex immunofluorescence. We identified a subset of SPP1 + macrophages that secrete SPP1 signals interacting with CD44 on malignant cell surfaces, potentially activating the PDE3B pathway within malignant cells via the integrin pathway, leading to chemotherapy resistance. The abnormally enhanced SPP1 signal between macrophages and malignant cells may serve as a factor promoting chemotherapy resistance in TNBC patients. Therefore, SPP1 + macrophages could potentially serve as a therapeutic target to reduce chemotherapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xinjiang Medical University Affiliated Cancer Hospital, Urumqi, China.
- Anhui Medical University, Hefei, China.
- Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, China.
ORCID-Profile: Fuzhong Liu
Förderung
- Xinjiang Medical University Scientific Research Innovation Team Project
- Xinjiang Uygur Autonomous Region Natural Science Foundation
- Tianchi Young Talent Doctoral Program
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
- The National Natural Science Foundation of China
Zitieren
APA
Liu, F., Zhang, J., Gu, X., Guo, Q., & Guo, W. (2024). Single‐cell transcriptome sequencing reveals SPP1 ‐ CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC. Journal of Cellular and Molecular Medicine, 28(13). https://doi.org/10.1111/jcmm.18525
Vancouver
Liu F, Zhang J, Gu X, Guo Q, Guo W. Single‐cell transcriptome sequencing reveals SPP1 ‐ CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC. Journal of Cellular and Molecular Medicine. 2024;28(13). doi:10.1111/jcmm.18525
BibTeX
@article{Liu2024,
author = {Liu, Fuzhong and Zhang, Junfeng and Gu, Xiaowei and Guo, Qiuyang and Guo, Wenjia},
title = {Single‐cell transcriptome sequencing reveals SPP1 ‐ CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {13},
doi = {10.1111/jcmm.18525}
}
EUVIMED